September 16, 2026 12:04 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Gurugram biker hit by car: Two including main accused arrested after viral road rage video, attempt to murder case filed | Gurugram horror caught on camera: ‘I felt unsafe’—car chases, rams woman biker and flees | BRICS veg menu row: ‘Why shouldn’t we showcase it?’—Harsh Goenka hits back after Rahul Gandhi’s ‘80%’ remark | India-UAE Comprehensive Strategic Partnership in focus: Modi meets Abu Dhabi Crown Prince on BRICS sidelines | Xi Jinping lands in India for BRICS; big Modi meeting set for New Delhi | ‘Hospitality on another level’: South African official stunned by India’s BRICS hosting | Suvendu Adhikari eats fish bhog at Kalighat Temple amid Bageshwar Baba row | Bangladeshi Hindu monk Chinmoy Krishna Das breaks down emotionally as he gets 5-hour parole to attend mother’s funeral | Sheikh Hasina’s daughter Saima Wazed quits WHO post amid fraud allegations | After days of silence, China confirms Xi Jinping’s India visit for BRICS Summit
Serum Institute
PIB

Had a good interaction with team: Indian PM Narendra Modi tweets after visiting Serum Institute of India

| @indiablooms | Nov 29, 2020, at 12:38 am

Pune: Indian PM Narendra Modi on Saturday visited Pune's Serum Institute of India, which is working on the coronavirus vaccine, and interacted with the team at the Institute.

"They shared details about their progress so far on how they plan to further ramp up vaccine manufacturing," read a government statement.

In a tweet, the Prime Minister said, "Had a good interaction with the team at Serum Institute of India. They shared details about their progress so far on how they plan to further ramp up vaccine manufacturing. Also took a look at their manufacturing facility."  

The institute's CEO Adar Poonawala thannked PM and tweeted: "Thank you @narendramodi for visiting @SerumInstIndia . We share your vision and continue to work towards ensuring a safe and secure India."

The PM earlier in the day visited  Bharat Biotech International Limited (BBIL) at Genome Valley in Shamirpet and reviewed the progress on the manufacturing of indigenous COVID-19 vaccine 'Covaxin'.

In Ahmedabad, he reviewed the vaccine development process at the Zydus Cadila research centre in Changodar industrial area.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.